Clinical Trial Update: Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating biologically guided radiation therapy (BgRT) and stereotactic body radiation therapy (SBRT) in combination with a tyrosine kinase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: City of Hope Medical Center | Conditions: Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | Phase 2 | Status: RECRUITING